S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
PG · Procter & Gamble Company
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Procter & Gamble Co (PG)
NEW YORK STOCK EXCHANGE, INC.
Consumer products
$156.84
-2.55
(-1.60%)
● At close: October 21 at 4:00:00 PM EDT
$158.27
+1.43
(+0.91%)
After-Hours:
5:49:20 PM EDT
DAY'S RANGE
$156.84
$156.83
$158.52
52-WEEK RANGE
$156.84
$137.62
$167.25
What's happening
- PG is down 1.60% today, trading at $156.84. — Live quote
- Volume today (712,561) is well below its 3-month average of 8,979,480. (Finnhub fundamentals)
- Reports earnings on 2026-10-22 (before market open), 1 day away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $1.43 actual vs. $1.45 estimated (-1.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 12
Hold 16
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (35 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
PG
+11.17%
vs S&P 500
-1.61%
1-YEAR RETURN
PG
+4.84%
vs S&P 500
-9.72%
6-MONTH RETURN
PG
+11.33%
3-MONTH RETURN
PG
+7.58%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$1.43
Est. $1.45
MISS -1.5%
2026-04-26 (Q1 2026)
$1.59
Est. $1.60
MISS -0.8%
2025-07-26 (Q4 2025)
$1.48
Est. $1.46
BEAT +1.2%
2025-04-26 (Q3 2025)
$1.54
Est. $1.57
MISS -2.0%
Valuation Measures & Ratios
Enterprise Value4$392.60B
Forward P/E520.97
PEG Ratio64.59
Price / Sales (TTM1)4.23
Price / Book76.29
EV4 / Revenue4.51
EV4 / EBITDA17.01
Profit Margin18.43%
Operating Margin22.89%
Return on Equity (ROE8)29.83%
Return on Assets (ROA9)12.59%
Avg Volume (3M)8,979,480
Quarterly history (5 periods)
| Measure | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|
| Market cap | $343.29B | $340.23B | $363.56B | $399.71B | $393.60B |
| P/E | 20.47 | 19.48 | 21.25 | 24.81 | 24.89 |
| Price/Sales | 4.01 | 3.94 | 4.24 | 4.78 | 4.62 |
| EV/Revenue | 4.29 | 4.24 | 4.52 | 5.07 | 4.91 |
| EV/EBITDA | 15.69 | 14.94 | 15.62 | — | — |
| ROA | 13.06% | 13.72% | 13.41% | 13.10% | 12.89% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short24,424,642
Change from Prior Settlement+0.87%
% of Float—
Days to Cover (Short Ratio)3.24
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 1.5% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 18.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is +4.8%. Finnhub market metrics ↗
Potential concerns
- Latest SEC filing is Form 8-K, filed 2026-10-16; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PG
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 | Sep '24 | Mar '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.23B | $22.21B | $22.39B | $19.78B | $21.88B | $21.74B | $20.20B | $21.44B |
| Operating income | $4.58B | $5.37B | $5.86B | $4.56B | $5.74B | $5.80B | $4.46B | $4.43B |
| Net income | $3.93B | $4.32B | $4.75B | $3.77B | $4.63B | $3.96B | $3.75B | $3.47B |
| EPS (diluted) | $1.63 | $1.78 | $1.95 | $1.54 | $1.88 | $1.61 | $1.52 | $1.40 |
| EPS (basic) | $1.66 | $1.82 | $2.00 | $1.58 | $1.94 | $1.65 | $1.56 | $1.44 |
| Operating margin | $22 | $24 | $26 | $23 | $26 | $27 | $22 | $21 |
| Net margin | $19 | $19 | $21 | $19 | $21 | $18 | $19 | $16 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $126.52B | $128.38B | $127.29B | $127.60B | $125.23B | $122.98B | $122.64B | $126.48B |
| Total liabilities | $72.21B | $73.65B | $73.97B | $74.05B | $72.95B | $70.44B | $71.19B | $74.34B |
| Total current assets | $26.21B | $27.99B | $26.59B | $27.12B | $25.39B | $24.43B | $25.64B | $27.45B |
| Total current liabilities | $38.69B | $38.23B | $36.70B | $37.99B | $36.06B | $34.25B | $33.80B | $36.42B |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Accounts receivable | $6.06B | $6.32B | $6.28B | $6.49B | $6.18B | $6.14B | $6.23B | $6.31B |
| Inventory | $8.17B | $7.85B | $7.82B | $7.85B | $7.55B | $7.40B | $7.02B | $7.29B |
| Property, plant & equipment | $25.36B | $24.57B | $24.49B | $24.12B | $23.90B | $22.73B | $22.07B | $22.51B |
| Goodwill | $41.28B | $41.36B | $41.66B | $41.64B | $41.65B | $40.48B | $39.90B | $40.97B |
| Intangible assets | $21.44B | $21.53B | $21.74B | $21.82B | $21.91B | $21.84B | $21.83B | $22.05B |
| Other non-current assets | $12.23B | $12.93B | $12.81B | $12.90B | $12.38B | $13.51B | $13.19B | $13.50B |
| Accounts payable | $16.31B | $15.03B | $15.17B | $15.61B | $15.23B | $14.51B | $14.49B | $15.35B |
| Accrued liabilities | $11.09B | $10.03B | $10.46B | $10.76B | $11.32B | $9.85B | $9.88B | $10.66B |
| Short-term debt | $4.84B | — | — | — | $4.11B | — | — | — |
| Other current liabilities | $3.04B | — | — | — | $2.92B | — | — | — |
| Long-term debt | $22.84B | $23.85B | $25.58B | $24.32B | $25.00B | $24.25B | $25.26B | $25.74B |
| Other non-current liabilities | $4.91B | $5.51B | $5.72B | $5.84B | $6.12B | $5.46B | $5.41B | $5.76B |
| Common stock & paid-in capital | $4.01B | $4.01B | $4.01B | $4.01B | $4.01B | $4.01B | $4.01B | $4.01B |
| Retained earnings | $135.85B | $135.42B | $133.98B | $132.21B | $129.97B | $128.92B | $127.54B | $125.36B |
| Accumulated other comprehensive income (loss) | -$12.46B | -$12.30B | -$12.11B | -$12.16B | -$12.14B | -$11.31B | -$11.64B | -$10.89B |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.13B | $4.04B | $4.97B | $5.41B | $4.99B | $3.71B | $4.83B | $4.30B |
| Investing cash flow | -$1.20B | -$665.0M | -$1.23B | -$1.53B | -$1.06B | -$726.0M | -$921.0M | -$1.11B |
| Financing cash flow | -$6.31B | -$1.83B | -$4.09B | -$2.24B | -$3.62B | -$4.21B | -$5.57B | -$634.0M |
| Free cash flow | $4.11B | $3.03B | $3.81B | $4.21B | $3.99B | $2.85B | $3.90B | $3.31B |
| Capital expenditures | $1.02B | $1.02B | $1.17B | $1.20B | $996.0M | $859.0M | $925.0M | $993.0M |
| Depreciation & amortization | $2.40B | $785.0M | $803.0M | $761.0M | $2.12B | $690.0M | $706.0M | $728.0M |
| Share-based compensation | $130.0M | $132.0M | $141.0M | $121.0M | $112.0M | $123.0M | $136.0M | $105.0M |
| Deferred income taxes | -$127.0M | -$18.0M | $143.0M | $53.0M | -$34.0M | -$38.0M | $37.0M | $184.0M |
| Change in accounts receivable | -$270.0M | $94.0M | -$213.0M | $305.0M | -$124.0M | -$183.0M | $128.0M | $134.0M |
| Change in inventory | $295.0M | $91.0M | -$48.0M | $303.0M | -$85.0M | $239.0M | -$18.0M | $188.0M |
| Change in accounts payable | $723.0M | -$43.0M | -$409.0M | $648.0M | $5.0M | -$261.0M | -$376.0M | $90.0M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Dividends paid | $2.61B | $2.53B | $2.54B | $2.55B | $2.55B | $2.43B | $2.44B | $2.44B |
| Share repurchases | $875.0M | $625.0M | $2.28B | $1.25B | $700.0M | $1.35B | $2.51B | $1.94B |
| Debt issued | $0 | $0 | $2.65B | — | $1.24B | $0 | $995.0M | — |
| Debt repaid | $1.03B | $1.36B | $1.00B | $3.0M | $499.0M | $0 | $1.41B | $70.0M |
Income statement
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Revenue | $87.03B | $84.28B | $84.04B | $82.01B | $80.19B |
| Operating income | $19.75B | $20.45B | $18.55B | $18.13B | $17.81B |
| Net income | $16.05B | $15.97B | $14.88B | $14.65B | $14.74B |
| EPS (diluted) | $6.62 | $6.51 | $6.02 | $5.90 | $5.81 |
| EPS (basic) | $6.75 | $6.67 | $6.18 | $6.07 | $6.00 |
| Operating margin | $23 | $24 | $22 | $22 | $22 |
| Net margin | $18 | $19 | $18 | $18 | $18 |
Balance sheet
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Total assets | $126.52B | $125.23B | $122.37B | $120.83B | $117.21B |
| Total liabilities | $72.21B | $72.95B | $71.81B | $73.76B | $70.35B |
| Total current assets | $26.21B | $25.39B | $24.71B | $22.65B | $21.65B |
| Total current liabilities | $38.69B | $36.06B | $33.63B | $35.76B | $33.08B |
| Cash & equivalents | — | — | — | — | — |
| Accounts receivable | $6.06B | $6.18B | $6.12B | $5.47B | $5.14B |
| Inventory | $8.17B | $7.55B | $7.02B | $7.07B | $6.92B |
| Property, plant & equipment | $25.36B | $23.90B | $22.15B | $21.91B | $21.20B |
| Goodwill | $41.28B | $41.65B | $40.30B | $40.66B | $39.70B |
| Intangible assets | $21.44B | $21.91B | $22.05B | $23.78B | $23.68B |
| Other non-current assets | $12.23B | $12.38B | $13.16B | $11.83B | $10.98B |
| Accounts payable | $16.31B | $15.23B | $15.36B | $14.60B | $14.88B |
| Accrued liabilities | $11.09B | $11.32B | $11.07B | $10.93B | $9.55B |
| Short-term debt | $4.84B | $4.11B | $3.33B | $6.24B | $4.80B |
| Other current liabilities | $3.04B | $2.92B | $2.95B | $2.92B | $2.94B |
| Long-term debt | $22.84B | $25.00B | $25.27B | $24.38B | $22.85B |
| Other non-current liabilities | $4.91B | $6.12B | $6.40B | $7.15B | $7.62B |
| Common stock & paid-in capital | $4.01B | $4.01B | $4.01B | $4.01B | $4.01B |
| Retained earnings | $135.85B | $129.97B | $123.81B | $118.17B | $112.43B |
| Accumulated other comprehensive income (loss) | -$12.46B | -$12.14B | -$11.90B | -$12.22B | -$12.19B |
Cash flow
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Operating cash flow | $19.56B | $17.82B | $19.85B | $16.85B | $16.72B |
| Investing cash flow | -$4.62B | -$3.82B | -$3.50B | -$3.50B | -$4.42B |
| Financing cash flow | -$14.46B | -$14.04B | -$14.86B | -$12.15B | -$14.88B |
| Free cash flow | $15.15B | $14.04B | $16.52B | $13.79B | $13.57B |
| Capital expenditures | $4.41B | $3.77B | $3.32B | $3.06B | $3.16B |
| Depreciation & amortization | $3.16B | $2.85B | $2.90B | $2.71B | $2.81B |
| Share-based compensation | $524.0M | $476.0M | $562.0M | $545.0M | $528.0M |
| Deferred income taxes | $51.0M | $149.0M | -$244.0M | -$453.0M | -$402.0M |
| Change in accounts receivable | -$84.0M | -$45.0M | $766.0M | $307.0M | $694.0M |
| Change in inventory | $641.0M | $324.0M | $70.0M | $119.0M | $1.25B |
| Change in accounts payable | $919.0M | -$542.0M | $878.0M | -$447.0M | — |
| Dividends paid | $10.23B | $9.87B | $9.31B | $9.00B | $8.77B |
| Share repurchases | $5.03B | $6.50B | $5.01B | $7.35B | $10.00B |
| Debt issued | $2.65B | $2.24B | $3.20B | $4.00B | $4.38B |
| Debt repaid | $3.39B | $1.98B | $2.33B | $1.88B | $2.34B |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PG as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers48.5%
Shares Outstanding2,333,700,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 190,003,442 | $27.86B | 8.14% | +1.6% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 152,109,741 | $22.31B | 6.52% | +0.7% | 2026-06-30 |
| State Street Corp | 102,216,308 | $14.99B | 4.38% | +1.0% | 2026-08-07 |
| GEODE CAPITAL MANAGEMENT, LLC | 66,458,472 | $9.74B | 2.85% | +3.2% | 2026-08-12 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 63,393,374 | $9.30B | 2.72% | +0.9% | 2026-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 47,243,680 | $6.93B | 2.02% | +14.2% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 47,243,680 | $6.93B | 2.02% | +0.0% | 2026-08-13 |
| Morgan Stanley | 47,157,141 | $6.92B | 2.02% | -4.2% | 2026-08-11 |
| NORGES BANK | 31,831,692 | $4.67B | 1.36% | +0.0% | 2026-08-12 |
| FMR LLC | 29,298,374 | $4.30B | 1.26% | -4.6% | 2026-08-13 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 28,906,005 | $4.2M | 1.24% | -9.9% | 2026-08-14 |
| Franklin Templeton Inc | 26,820,010 | $3.93B | 1.15% | -3.5% | 2026-08-04 |
| Northern Trust Corp | 26,787,336 | $3.93B | 1.15% | -1.2% | 2026-08-12 |
| Bank Of America Corp /De/ | 26,259,055 | $3.85B | 1.13% | -0.3% | 2026-08-14 |
| Jpmorgan Chase & Co | 23,668,565 | $3.51B | 1.01% | -28.7% | 2026-08-12 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 17,219,256 | $2.53B | 0.74% | -6.1% | 2026-08-13 |
| Goldman Sachs Group Inc | 16,773,067 | $2.46B | 0.72% | -3.2% | 2026-08-14 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 15,800,799 | $2.32B | 0.68% | +0.0% | 2026-07-28 |
| Bank of New York Mellon Corp | 15,558,541 | $2.28B | 0.67% | -2.9% | 2026-08-06 |
| Capital World Investors | 15,416,034 | $2.26B | 0.66% | +107.3% | 2026-08-07 |
| Royal Bank Of Canada | 15,027,411 | $2.20B | 0.64% | +6.4% | 2026-08-13 |
| Legal & General Group Plc | 14,564,948 | $2.14B | 0.62% | -10.1% | 2026-08-14 |
| Wells Fargo & Company/Mn | 13,975,738 | $2.05B | 0.60% | -2.8% | 2026-08-14 |
| Ameriprise Financial Inc | 13,934,200 | $2.04B | 0.60% | -5.2% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 13,581,771 | $1.99B | 0.58% | +15.1% | 2026-08-11 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-10-01 to 2026-10-13
Recent transactions
- Insiders have net sold 8,508 shares over the last 182 days, across 0 purchases and 3 sales.
- Most recent: Subramaniam Rajesh (Director) — Grant / award of 1,438 shares on 2026-10-13.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)8,508 sh(3 txns)
Net Shares-8,508
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Subramaniam Rajesh | Director | Grant / award | 2026-10-13 | 1,438 |
| Portman Robert Jones | Director | Grant / award | 2026-10-13 | 1,438 |
| McEvoy Ashley | Director | Grant / award | 2026-10-13 | 1,438 |
| McCarthy Christine M | Director | Grant / award | 2026-10-13 | 1,438 |
| Kempczinski Christopher J | Director | Grant / award | 2026-10-13 | 1,438 |
| JIMENEZ JOSEPH | Director | Grant / award | 2026-10-13 | 1,438 |
| Chang Amy | Director | Grant / award | 2026-10-13 | 1,438 |
| Bonini Sheila | Director | Grant / award | 2026-10-13 | 1,438 |
| Biggs M. Brett | Director | Grant / award | 2026-10-13 | 1,438 |
| ARNOLD CRAIG | Director | Grant / award | 2026-10-13 | 1,438 |
| Allen Bertrand Marc | Director | Grant / award | 2026-10-13 | 1,438 |
| Schulten Andre | Chief Financial Officer | Open market sale | 2026-10-05 | 3,914 |
| Gama Paul | CEO- Health Care | Open market sale | 2026-10-05 | 2,225 |
| Whaley Susan Street | Chief Legal Officer & Secy | Open market sale | 2026-10-05 | 2,369 |
| Jejurikar Shailesh | Chairman, President and CEO | Grant / award | 2026-10-01 | 16,065 |
| Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | Grant / award | 2026-10-01 | 5,732 |
| Santos de Azevedo Juliana Monteiro | CEO - Grooming | Grant / award | 2026-10-01 | 3,130 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-13 | Subramaniam Rajesh | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | Portman Robert Jones | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | McEvoy Ashley | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | McCarthy Christine M | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | Kempczinski Christopher J | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | JIMENEZ JOSEPH | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | Chang Amy | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | Bonini Sheila | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | Biggs M. Brett | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | ARNOLD CRAIG | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-13 | Allen Bertrand Marc | Director | Grant / award | 1,438 | $0.00 |
| 2026-10-05 | Schulten Andre | Chief Financial Officer | Open market sale | 3,914 | $145.34 |
| 2026-10-05 | Gama Paul | CEO- Health Care | Open market sale | 2,225 | $145.34 |
| 2026-10-05 | Whaley Susan Street | Chief Legal Officer & Secy | Open market sale | 2,369 | $145.34 |
| 2026-10-01 | Whaley Susan Street | Chief Legal Officer & Secy | Grant / award | 6,110 | $0.00 |
| 2026-10-01 | Schulten Andre | Chief Financial Officer | Grant / award | 6,557 | $0.00 |
| 2026-10-01 | Gama Paul | CEO- Health Care | Grant / award | 12,517 | $0.00 |
| 2026-10-01 | Jejurikar Shailesh | Chairman, President and CEO | Grant / award | 16,065 | $0.00 |
| 2026-10-01 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | Grant / award | 5,732 | $0.00 |
| 2026-10-01 | Santos de Azevedo Juliana Monteiro | CEO - Grooming | Grant / award | 3,130 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:04 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-16 | 8-K | 2026-10-16 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
| 2026-10-14 | 4 | 2026-10-13 | View on SEC.gov → |
Recent news
Headlines about PG (Procter & Gamble Company). Links open the publisher — we don’t host full articles.
-
Procter & Gamble (NYSE:PG) Stock Price Down 1.5% - What's Next?
MarketBeat · 2026-10-21 -
U.S. Markets Rally as Investors Eye Procter & Gamble's Upcoming Earnings (PG)
GuruFocus · 2026-10-21 -
Procter & Gamble Co. stock underperforms Wednesday when compared to competitors
MarketWatch · 2026-10-21 -
Stock Market Today: Nasdaq Vaults On SpaceX Report; Software Names Gain (Live Coverage)
Yahoo · 2026-10-21 -
Procter & Gamble (PG) Expects 1% to 3% Organic Growth, Is That Enough?
Yahoo · 2026-10-21 -
Treasury Yields Are Near 5%. Should Retirees Rethink Dividend Stocks?
Yahoo · 2026-10-21 -
Procter & Gamble (PG) Set to Report Q1 Earnings Amid Dividend Su
GuruFocus · 2026-10-21 -
Ahead of Procter & Gamble Earnings, Here's What Barchart Data Says Comes Next for PG Stock
Yahoo Finance · 2026-10-21
No headlines in this category right now — try “All”.